Shanghai Hile Bio-Technology Co., Ltd. logo

Shanghai Hile Bio-Technology Co., Ltd. (603718)

Market Closed
11 Aug, 06:57
SSE SSE
¥
2. 95
-0.02
-0.6734%
¥
4.59B Market Cap
- P/E Ratio
0.11% Div Yield
4.83M Volume
- Eps
¥ 2.97
Previous Close
Add Transaction
Day Range
2.93 2.99
Year Range
2.57 7.7
Want to track 603718 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603718 closed today lower at ¥2.95, a decrease of -0.6734% from yesterday's close, completing a monthly increase of 11.3208% or ¥0.3. Over the past 12 months, 603718 stock lost -52.1104%.
603718 pays dividends to its shareholders, with the most recent payment made on Jul 15, 2025. The next estimated payment will be in 3 weeks ago on Jul 15, 2026 for a total of ¥0.0784.
The last earnings report, released on May 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0105%, based on the last three reports.
Shanghai Hile Bio-Technology Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 05, 2016.
The company's stock is traded on one exchange.

603718 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Shanghai Hile Bio-Technology Co., Ltd. (603718) FAQ

What is the stock price today?

The current price is ¥2.95.

On which exchange is it traded?

Shanghai Hile Bio-Technology Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603718.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.11%.

What is its market cap?

As of today, the market cap is 4.59B.

Has Shanghai Hile Bio-Technology Co., Ltd. ever had a stock split?

Shanghai Hile Bio-Technology Co., Ltd. had 1 splits and the recent split was on May 05, 2016.

Shanghai Hile Bio-Technology Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Ms. Qun Lin CEO
SSE Exchange
CNE1000022T4 ISIN
CN Country
295 Employees
15 Jul 2025 Last Dividend
5 May 2016 Last Split
- IPO Date

Overview

Shanghai Hile Bio-Technology Co., Ltd., founded in 1981 and headquartered in Shanghai, China, specializes in the research, development, production, and sale of veterinary biological products. The company focuses on livestock and poultry, providing a comprehensive portfolio of vaccines to address various diseases and conditions. The dedication to innovation and quality has established Shanghai Hile Bio-Technology as a significant player in the veterinary pharmaceutical industry within China.

Products and Services

The company's product line is designed to meet the diverse needs of poultry and livestock health management. Below is a detailed breakdown of their offerings:

  • Swine Fever Live Vaccines: Live vaccines aimed at preventing swine fever, a highly contagious disease in pigs.
  • Trivalent Inactivated Vaccines for Piglets: These vaccines offer protection against three different diseases in piglets, enhancing their immunity during the early stages of life.
  • Inactivated Vaccine for Streptococcus suis: Targets the bacteria Streptococcus suis, providing immunity against this pathogen that can cause a broad range of diseases in pigs, from meningitis to pneumonia and arthritis.
  • Inactivated Avian Infectious Rhinitis Vaccines: Specifically designed to prevent avian infectious rhinitis, a disease that affects the respiratory system of birds.
  • Newcastle Disease and Avian Influenza Combined Inactivated Vaccines: These vaccines protect poultry from Newcastle disease and avian influenza, both highly contagious viral diseases with high mortality rates.
  • Newcastle Disease, Infectious Bronchitis, Egg Drop Syndrome, and Avian Influenza Quadruple Inactivated Vaccines: Offer comprehensive protection against four significant threats to poultry health in one vaccine.
  • Avian Influenza Inactivated Vaccines: Focused on immunizing birds against avian influenza, a contagious viral infection that can spread rapidly among flocks.
  • Newcastle Disease, Infectious Bronchitis, and Avian Influenza Triple Inactivated Vaccines: A combination vaccine offering protection against three of the most critical poultry diseases.
  • Avian Infectious Bronchitis Live Vaccines: Live vaccines designed to protect poultry from infectious bronchitis, a disease that affects the respiratory, renal, and reproductive systems of birds.
  • Avian Newcastle Disease, and Avian Infectious Bronchitis Combined Live Vaccines: These live vaccines offer simultaneous protection against both Newcastle disease and avian infectious bronchitis, helping to maintain flock health and productivity.

Contact Information

Address: Room 1805, Shanghai, China, 200021
Phone: 86 21 6089 0888